“Biological Evaluation of 2,3-Dioxoindolin-N-Phenylacetamide Derivatives As Potent CDC25B and PTP1B Phosphatase Inhibitors”. Brazilian Journal of Pharmaceutical Sciences, vol. 56, Dec. 2020, p. e00222, https://doi.org/10.1590/s2175-97902019000400222.